41 related articles for article (PubMed ID: 9279772)
1. NSAIDs inhibit tumorigenesis, but how?
Gurpinar E; Grizzle WE; Piazza GA
Clin Cancer Res; 2014 Mar; 20(5):1104-13. PubMed ID: 24311630
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.
Zhao F; Zhao W
J Fluoresc; 2012 Jan; 22(1):529-35. PubMed ID: 21968509
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis factor-α and Nitric Oxide Production In Vitro.
Park KS; Kim BH; Chang IM
Evid Based Complement Alternat Med; 2010 Mar; 7(1):41-5. PubMed ID: 18955286
[TBL] [Abstract][Full Text] [Related]
4. Selective prostaglandin G/H synthase (PGHS)-2 inhibitors show greater inhibitory activities on human PGHS-2 than on murine PGHS-2 in intact cells.
Berg J; Fellier H; Bodenteich A; Christoph T; Towart R
Inflammopharmacology; 1997; 5(2):119-26. PubMed ID: 17694360
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Lornoxicam and Rofecoxib in Patients with Activated Osteoarthritis (COLOR Study).
Rose P; Steinhauser C
Clin Drug Investig; 2004; 24(4):227-36. PubMed ID: 17516707
[TBL] [Abstract][Full Text] [Related]
6. What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.
Scott A; Khan KM; Roberts CR; Cook JL; Duronio V
Br J Sports Med; 2004 Jun; 38(3):372-80. PubMed ID: 15155453
[TBL] [Abstract][Full Text] [Related]
7. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
Buttar NS; Wang KK
Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
9. A model with original conditions and materials to test potential inhibitors of cyclooxygenase-2 versus cyclooxygenase-1 in isolated human blood cells.
Siomboing X; D'Hondt O; Luyckx M; Gressier B; Dine T; Brunet C
Methods Find Exp Clin Pharmacol; 2003 Apr; 25(3):175-81. PubMed ID: 12743620
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes.
Kato M; Nishida S; Kitasato H; Sakata N; Kawai S
J Pharm Pharmacol; 2001 Dec; 53(12):1679-85. PubMed ID: 11804398
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
13. Synergy between cyclo-oxygenase-2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy.
Hamilton LC; Mitchell JA; Tomlinson AM; Warner TD
FASEB J; 1999 Feb; 13(2):245-51. PubMed ID: 9973312
[TBL] [Abstract][Full Text] [Related]
14. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6.
Berg J; Christoph T; Widerna M; Bodenteich A
J Pharmacol Toxicol Methods; 1997 Jun; 37(4):179-86. PubMed ID: 9279772
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
